Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it ...

Detailed price information for Moonlake Immunotherapeutics (MLTX-Q) from The Globe and Mail including charting and trades.

Conshohocken, Pennsylvania Thursday, August 21, 2025, 14:00 Hrs [IST] ...

60-Day IL (lat), Nick Madrigal: 60-Day IL (shoulder), Drew Smith: 60-Day IL (elbow), Christian Scott: 60-Day IL (elbow) The Associated Press created this story using technology provided by Data Skrive ...

MDGL wins EU nod for Rezdiffra as the first and only approved MASH therapy. The drug's launch in Europe is expected in the fourth quarter of 2025.

Madrigal Pharmaceuticals ( NASDAQ: MDGL) has received conditional marketing approval from the European Commission for ...

The European Commission (EC) has granted conditional marketing authorization for Madrigal Pharmaceuticals' Rezdiffra (resmetirom) for the treatment of adults with noncirrhotic metabolic ...

Madrigal Pharmaceuticals’ Rezdiffra (resmetirom) has been approved in Europe for the treatment of metabolic ...

Nationals +151; over/under is 9 runs. BOTTOM LINE: The New York Mets will attempt to extend a three-game win streak with a victory over the Wash ...

Lebowitz covers the Healthcare sector, focusing on stocks such as Incyte, Schrodinger, and Madrigal Pharmaceuticals. Viking Therapeutics has an analyst consensus of Strong Buy, with a price target ...

PITCHING PROBABLES: Mets: David Peterson (7-5, 3.30 ERA, 1.28 WHIP, 117 strikeouts); Nationals: Jake Irvin (8-7, 5.14 ERA, 1.38 WHIP, 94 strikeouts) ...

EXCLUSIVE: All Things Comedy, the comedy podcast network and production company founded by Bill Burr and Al Madrigal, has ...